|
|
Article: The HPV vaccine: lowering cancer risk; Nearly 10,000 U.S. women are newly diagnosed with cervical cancer each year, and 3,700 die from it. Here's the information you need about the medical advancement that could bring those numbers way down.(human papillomavirus)(Interview)
- Article from:
- Cortlandt Forum
- Article date:
- July 1, 2006
CopyrightCOPYRIGHT 2006 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In the ongoing war on cancer, the new human papillomavirus (HPV) vaccine has been hailed as a breakthrough. "This is a watershed event," proclaimed American Cancer Society president Carolyn Runowicz in an interview with the Chicago Tribune--an event "we hope will help usher in a new era."
The vaccine, Merck's Gardasil, was approved by the FDA on June 8, 2006, and should be commercially available in the late summer or autumn. It targets four strains of HPV: HPV-16 and HPV-18, which account for 70% of all cases of cervical cancer, as well as HPV-6 and HPV-11, which are responsible for about 90% of genital warts. The vaccine is administered in three shots over six ...